ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
38 announcements
Dishman Carbogen Amcis Ltd paid ₹3.09 Crore towards interest and partial redemption of NCDs (ISIN: INE385W07034) on April 28, 2026. The payment followed a put option exercise by debenture holders for 300 units.
Dishman Carbogen Amcis Ltd paid ₹1.23 Crore in interest and redeemed ₹4.17 Crore in principal for its NCDs (ISIN: INE385W07059) on April 18, 2026. The total payment of ₹5.40 Crore represents the first quarterly obligation for the secured, rated NCDs, with a post-redemption outstanding face value of ₹91,666.67 per unit.
Dishman Carbogen Amcis Limited has appointed Mr. Sandeep Jaiswal as Vice President - International Marketing, effective April 20, 2026. Mr. Jaiswal brings 27 years of experience in API and specialty chemicals marketing, previously serving at Apotex Pharmachem India. This appointment strengthens the company's senior leadership and international business development capabilities.
Dishman Carbogen Amcis Limited appointed Mr. Sandeep Jaiswal as Vice President - International Marketing, effective April 20, 2026. Mr. Jaiswal brings 27 years of experience in API and specialty chemicals marketing, previously serving at Apotex Pharmachem India. This strategic hire aims to strengthen the company's international business development and marketing leadership.
Dishman Carbogen Amcis Limited has appointed Mr. Sandeep Jaiswal as Vice President (International Marketing) effective April 20, 2026. Mr. Jaiswal brings 27 years of experience in the pharmaceuticals and chemicals sectors, previously serving as General Manager – Marketing at Apotex Pharmachem India.
Dishman Carbogen Amcis Limited submitted its annual disclosure for Non-Convertible Debentures (NCDs) for the period ended March 31, 2026. The filing includes listing details, hyperlinks to exchange notifications, and current credit ratings from India Ratings & Research. The company confirmed that all interest and redemption payments due up to the period end were successfully made.
Dishman Carbogen Amcis Limited submitted its half-yearly statement of private placement of debt securities for the period ended March 31, 2026. The company reported three outstanding NCD series with a total outstanding value of ₹135.38 Crore. This filing ensures regulatory compliance regarding its non-convertible debenture obligations.
Dishman Carbogen Amcis Ltd has fixed April 15, 2026, as the record date for interest payment and partial redemption of 300 NCD units (ISIN: INE385W07034). The payment is scheduled for April 30, 2026, following the exercise of a put option by certain debenture holders.